These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19879422)

  • 1. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.
    Mazzarelli P; Pucci S; Spagnoli LG
    Adv Cancer Res; 2009; 105():45-61. PubMed ID: 19879422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression.
    Pucci S; Mazzarelli P; Sesti F; Boothman DA; Spagnoli LG
    Cell Cycle; 2009 Feb; 8(3):473-81. PubMed ID: 19177010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin in stool: a new biomarker for colon cancer screening?
    Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
    Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLU "in and out": looking for a link.
    Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
    Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
    Trougakos IP; Lourda M; Antonelou MH; Kletsas D; Gorgoulis VG; Papassideri IS; Zou Y; Margaritis LH; Boothman DA; Gonos ES
    Clin Cancer Res; 2009 Jan; 15(1):48-59. PubMed ID: 19118032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
    Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
    Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
    Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
    Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLU blocks HDACI-mediated killing of neuroblastoma.
    Subramanian C; Jarzembowski JA; Halsey SM; Kuick R; Opipari AW; Castle VP; Kwok RP
    Tumour Biol; 2011 Apr; 32(2):285-94. PubMed ID: 21042904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
    Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
    Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.
    Yang CR; Leskov K; Hosley-Eberlein K; Criswell T; Pink JJ; Kinsella TJ; Boothman DA
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5907-12. PubMed ID: 10823943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.
    Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
    J Mol Histol; 2006 Sep; 37(5-7):183-8. PubMed ID: 17048076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
    Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin and chemoresistance.
    Djeu JY; Wei S
    Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 4: Regulation of Clusterin activity by calcium.
    Pajak B; Orzechowski A
    Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
    Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
    Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
    Redondo M; Tellez T; Roldan MJ
    Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
    Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
    Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage.
    Ricci F; Pucci S; Sesti F; Missiroli F; Cerulli L; Spagnoli LG
    Ophthalmic Res; 2007; 39(3):164-73. PubMed ID: 17534116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.